Internal Medicine, Endocrinology, Diabetes, & Metabolism · Hot Springs, AR
NPI
1275742884
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1662 Higdon Ferry Rd., Ste 230
Hot Springs, AR, 71913
Phone (501) 623-9581
Groups this clinician bills Medicare through
Medicare paid, 2024
$151K
4,351 services
Medicare patients, 2024
640
Average age 70
Drug cost, 2024
$2.0M
4,569 prescriptions
Company payments, 2025
$1,465
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan A Stringer was code J0897 (injection, denosumab, 1 mg), 1,380 times for 12 patients. In total Jonathan A Stringer billed 4,351 services in 18 codes, and Medicare paid $151K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 12 | $20.36 | $28K |
| 99214 Office E&M - Established | Office | 1,031 | 560 | $80.64 | $83K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 650 | 446 | $11.42 | $7,421 |
| 83036 Blood Count | Office | 606 | 352 | $9.42 | $5,710 |
| 95251 Test - Miscellaneous | Office | 502 | 254 | $23.87 | $12K |
| 99213 Office E&M - Established | Office | 54 | 49 | $48.06 | $2,595 |
| 99215 Office E&M - Established | Office | 45 | 30 | $128.78 | $5,795 |
| 99204 Office E&M - New | Office | 31 | 31 | $93.76 | $2,907 |
| 96372 Injection Administration | Office | 23 | 12 | $8.84 | $203 |
| 99205 Office E&M - New | Office | 14 | 14 | $147.88 | $2,070 |
By year: 2022 $79K for 2,158 services; 2023 $90K for 2,724 services; 2024 $151K for 4,351 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 606 | 352 | $9.42 | $5,710 |
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan A Stringer prescribed most often to Medicare patients was Levothyroxine Sodium, with 534 prescriptions and refills. In total Jonathan A Stringer wrote 4,569 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 534 | 1,200 | 130 | $4,248 |
| Mounjaro Tirzepatide | 288 | 345 | 38 | $366K |
| Tresiba Flextouch U-100 Insulin Degludec | 230 | 374 | 57 | $154K |
| Metformin Hcl Er Metformin Hcl | 201 | 493 | 57 | $1,484 |
| Ozempic Semaglutide | 196 | 240 | 38 | $217K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 179 | 316 | 49 | $24K |
| Novolog Flexpen Insulin Aspart | 171 | 253 | 51 | $48K |
| Jardiance Empagliflozin | 117 | 176 | 26 | $102K |
| Methimazole Generic | 109 | 201 | 21 | $516 |
| Synthroid Levothyroxine Sodium | 106 | 224 | 26 | $8,931 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 91 | 110 | 23 | $37K |
| Metformin Hcl Generic | 90 | 246 | 24 | $674 |
| Tresiba Flextouch U-200 Insulin Degludec | 88 | 111 | 12 | $100K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 81 | 179 | 27 | $8,628 |
| Farxiga Dapagliflozin Propanediol | 72 | 100 | 14 | $56K |
Brand drugs: 2,780 claims; generic drugs: 1,484 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan A Stringer $1,465 ($1,465 in general payments such as food, travel and fees) from 23 companies. The largest payer was Mannkind Corporation with $142.
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation MNKD | 5 | $142 |
| Medtronic, Inc. MDT | 7 | $136 |
| Lilly USA, LLC LLY | 7 | $107 |
| Tandem Diabetes Care, Inc. TNDM | 5 | $106 |
| Novo Nordisk Inc NVO | 5 | $93.52 |
| CeQur Corporation | 1 | $86 |
| Radius Health, Inc. | 3 | $84.36 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $79.13 |
| Recordati_rare_diseases_inc. | 3 | $76.8 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $68.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.